A 62-year-old male (weight 85 kg, BMI 27.5 kg/m2) with hypertension, type 2 diabetes, and a 3-year history of recurrent calcium oxalate nephrolithiasis (five documented episodes) presents with acute left flank pain. Vital signs are: T 36.8 °C, BP 120/78 mmHg, HR 78 /min, RR 18 /min, SpO2 98% on room air. Labs show serum calcium 10.8 mg/dL (8.6–10.2), creatinine 1.4 mg/dL (baseline 1.2), eGFR 55 mL/min/1.73 m2. A 24-hour urine collection demonstrates calcium 350 mg/day, oxalate 55 mg/day, citrate 200 mg/day. He lives in a rural community three hours from the nearest pharmacy and hospital and reports missing doses of prescribed hydrochlorothiazide and potassium citrate due to travel barriers. He also has limited health literacy and finds dietary and fluid recommendations confusing. Considering this patient’s clinical and social context, which social determinant of health is MOST critical to address to prevent future stone recurrences and optimize long-term management?

Regarding the epidemiological prevalence of calcium and magnesium abnormalities in critically ill patients in the intensive care unit, which of the following statements is most accurate?

A 65-year-old man with end-stage renal disease (ESRD) on thrice-weekly hemodialysis, type 2 diabetes mellitus, and hypertension is evaluated for progressive fatigue and muscle cramps. His laboratory values are: serum calcium 7.2 mg/dL (8.5–10.2 mg/dL), magnesium 1.1 mg/dL (1.7–2.3 mg/dL), phosphate 6.5 mg/dL (2.5–4.5 mg/dL), and intact parathyroid hormone (PTH) 350 pg/mL (15–65 pg/mL). Considering these findings, which pre-existing condition is most critically contributing to his hypocalcemia, hypomagnesemia, hyperphosphatemia, and elevated PTH, and should be the focus of long-term management?

A 52-year-old man is admitted with severe acute pancreatitis. On hospital day 3, he reports perioral numbness and muscle cramps. Despite receiving 2 g of intravenous calcium gluconate every 6 hours for 24 hours, his serum calcium remains low at 6.8 mg/dL (normal 8.5–10.2). Laboratory studies show magnesium 1.1 mg/dL (1.7–2.2), intact PTH 15 pg/mL (15–65), albumin 3.9 g/dL, creatinine 1.2 mg/dL. Which pathophysiological mechanism is the MOST critical to address to resolve his refractory hypocalcemia?

A 65-year-old man is found to have hypercalcemia on routine laboratory testing. His serum total calcium is 11.8 mg/dL (normal 8.5–10.5 mg/dL), ionized calcium is 1.45 mmol/L (normal 1.12–1.32 mmol/L), and serum albumin is within normal limits. His parathyroid hormone (PTH) level is elevated at 110 pg/mL (normal 15–65 pg/mL). Based on these findings, which of the following is the most likely etiology of his hypercalcemia?

A 45-year-old man with chronic alcoholism is admitted to the ICU with septic shock requiring norepinephrine infusion and mechanical ventilation. During his stay, he develops perioral paresthesias and generalized muscle cramps. His ECG shows a prolonged QT interval. Laboratory tests reveal a total serum calcium of 6.8 mg/dL (normal 8.5–10.5 mg/dL) and a magnesium level of 1.4 mg/dL (normal 1.7–2.2 mg/dL). Which physical examination finding is MOST specific for hypocalcemia rather than hypomagnesemia?

In a critically ill patient with severe symptomatic hypercalcemia (corrected serum calcium 15.2 mg/dL) presenting with lethargy, confusion, and ECG changes, which initial management strategy is most appropriate?

A 58-year-old critically ill patient in the ICU presents with carpopedal spasms, perioral numbness, and a prolonged QTc interval on ECG. Laboratory tests reveal hypocalcemia and hypomagnesemia. The patient has a central venous catheter in place. Considering the patient’s acute symptoms, laboratory values, and central venous access, which of the following is the MOST appropriate initial pharmacotherapy plan to prioritize and stabilize this patient?

A 62-year-old, 75-kg male in the medical ICU is noted to have symptomatic hypocalcemia (total calcium 6.8 mg/dL [normal 8.5–10.5], ionized calcium 0.72 mmol/L [normal 1.1–1.3]) and hypomagnesemia (serum magnesium 1.2 mg/dL [normal 1.7–2.4]). His serum creatinine is 0.9 mg/dL (CrCl ≈85 mL/min). He has an existing right internal jugular central venous catheter. Which of the following represents the MOST appropriate initial intravenous electrolyte repletion regimen, using safe administration practices?

A 58-year-old man with recurrent calcium oxalate nephrolithiasis presents for evaluation of long-term stone prevention. Stone analysis confirmed calcium oxalate composition. A 24-hour urine collection reveals hypercalciuria at 350 mg/day with normal citrate and uric acid excretion. Serum calcium is 9.4 mg/dL and eGFR is 85 mL/min/1.73 m². Considering pharmacoeconomic factors—including drug acquisition cost, monitoring requirements, and overall resource utilization—which of the following pharmacologic interventions is the most cost-effective for long-term prevention of recurrent calcium oxalate stones in this patient?